E-ISSN 2218-6050 | ISSN 2226-4485
 

Case Report


Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors

Eleanor M. Kellon, Kathleen M. Gustafson.


Cited By:2

Abstract
Background:
Sodium-Glucose CoTransporter-2 [SGLT2] inhibitors, the -flozin group of drugs, which block glucose reuptake in the renal proximal tubule, are being increasingly used off-label to treat horses with refractory hyperinsulinemia. After two years of use by animals in our group, a horse on canagliflozin was incidentally noted to be hyperlipemic.
Case Description:
We have been following a cohort of equines (n=20) treated with SGLT2 inhibitors due to refractory hyperinsulinemia. The animals are owned by members of the Equine Cushing’s and Insulin Resistance Group (ECIR) and treated by their attending veterinarians. The index case was a 23 year old gelding with a 2 year history of recurring laminitis that began canagliflozin therapy to control hyperinsulinemia which was no longer responsive to metformin. Between 6-10 weeks post therapy, significant weight loss was noticed. Two days later he was hospitalized with colic symptoms and hyperlipemia but was bright, alert and eating well throughout. Canagliflozin was discontinued and triglycerides returned to normal reference values within 10 days. Subsequent study of 19 other horses on SGLT2 inhibitors revealed varying degrees of hypertriglyceridemia, all asymptomatic.
Conclusion:
While this class of drugs holds great promise for cases of refractory hyperinsulinemia and laminitis that do not respond to diet or metformin therapy, hypertriglyceridemia is a potential side effect. In our experience, animals remained asymptomatic and eating well. Further study of hypertriglyceridemia in horses on SGLT2 inhibitors and the possible mitigating effect of diet is indicated. To our knowledge, this is the first published report of hypertriglyceridemia with SGLT2 inhibitor treatment in equines.

Key words: Equine, Hyperinsulinemia, Hypertriglyceridemia, Canagliflozin, Ertugliflozin


 
ARTICLE TOOLS
Abstract
PDF Fulltext
HTML Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Eleanor M. Kellon
Articles by Kathleen M. Gustafson
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Kellon EM, Gustafson KM. Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors. Open Vet J. 2023; 13(3): 365-375. doi:10.5455/OVJ.2023.v13.i3.14


Web Style

Kellon EM, Gustafson KM. Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors. https://www.openveterinaryjournal.com/?mno=128964 [Access: February 28, 2024]. doi:10.5455/OVJ.2023.v13.i3.14


AMA (American Medical Association) Style

Kellon EM, Gustafson KM. Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors. Open Vet J. 2023; 13(3): 365-375. doi:10.5455/OVJ.2023.v13.i3.14



Vancouver/ICMJE Style

Kellon EM, Gustafson KM. Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors. Open Vet J. (2023), [cited February 28, 2024]; 13(3): 365-375. doi:10.5455/OVJ.2023.v13.i3.14



Harvard Style

Kellon, E. M. & Gustafson, . K. M. (2023) Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors. Open Vet J, 13 (3), 365-375. doi:10.5455/OVJ.2023.v13.i3.14



Turabian Style

Kellon, Eleanor M., and Kathleen M. Gustafson. 2023. Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors. Open Veterinary Journal, 13 (3), 365-375. doi:10.5455/OVJ.2023.v13.i3.14



Chicago Style

Kellon, Eleanor M., and Kathleen M. Gustafson. "Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors." Open Veterinary Journal 13 (2023), 365-375. doi:10.5455/OVJ.2023.v13.i3.14



MLA (The Modern Language Association) Style

Kellon, Eleanor M., and Kathleen M. Gustafson. "Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors." Open Veterinary Journal 13.3 (2023), 365-375. Print. doi:10.5455/OVJ.2023.v13.i3.14



APA (American Psychological Association) Style

Kellon, E. M. & Gustafson, . K. M. (2023) Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors. Open Veterinary Journal, 13 (3), 365-375. doi:10.5455/OVJ.2023.v13.i3.14